Shares of Janux Therapeutics, Inc. (JANX) are trading -6% lower at a price of $11.66 at the time of this writing.

Janux Therapeutics, Inc. has been trading between a 52-week high of $35.93 and a 52-week low of $9.39. The stock has a market cap of $485 Million.

Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets. The Janux TRACTr development pipeline targets multiple solid tumor indications, including colorectal, gastroesophageal, prostrate, NSCLC, triple negative breast, and ovarian cancers.

Janux Therapeutics Inc. (NASDAQ: JANX) Stock Jumping 33.73% Over A Month – Any Room For Its Value To Rise?
Marketing Sentinel 07-09-22

Is Now A Good Time To Invest In Janux Therapeutics Inc. (NASDAQ: JANX)?
Stocks Register 06-25-22

Janux Therapeutics Inc. At $10.96: Buy, Sell Or Hold?
Marketing Sentinel 06-18-22

Janux Therapeutics to Present at 2022 Jefferies Global Healthcare Conference
Business Wire 06-02-22

FDA clears Janux''s new drug application for prostrate cancer treatment candidate JANX007
Seeking Alpha 05-31-22